Short answer · Medically reviewed summary · Last updated: 2026-05-08
Melanoma has been recognized as a clinical entity since antiquity, with the first modern scientific description provided by René Laennec in 1804. Our understanding of melanoma has evolved from viewing it as a mysterious "fatal black cancer" to a complex, genetically driven condition now treatable through targeted therapy and immunotherapy. When was melanoma first described? While Hippocrates described dark, fatal tumors in the 5th century BCE, the true medical history of melanoma began in 1804 when French physician René Laennec formally identified it as a distinct disease entity.
What is the history of Melanoma?
History of Melanoma: when and how it was discovered, and the milestones in research since, medically reviewed.
Melanoma has been recognized as a clinical entity since antiquity, with the first modern scientific description provided by René Laennec in 1804. Our understanding of melanoma has evolved from viewing it as a mysterious "fatal black cancer" to a complex, genetically driven condition now treatable through targeted therapy and immunotherapy.
When was melanoma first described?
While Hippocrates described dark, fatal tumors in the 5th century BCE, the true medical history of melanoma began in 1804 when French physician René Laennec formally identified it as a distinct disease entity. For much of the 19th and early 20th centuries, melanoma was considered almost universally fatal, as physicians lacked the tools to detect it early or treat metastatic spread effectively.
How has the understanding of melanoma evolved?
The 20th century transformed melanoma research through the development of the Clark and Breslow staging systems, which measure the depth of tumor invasion. These milestones allowed clinicians to predict outcomes accurately. In the 21st century, the field shifted toward molecular biology, revealing that melanoma is not a single disease but a collection of mutations, most notably the BRAF mutation found in approximately 50% of cutaneous cases.
What are the major milestones in treatment?
Treatment for melanoma has progressed significantly, shifting from radical surgery to systemic therapies that harness the body’s own immune system:
- 1970s: Wide excision surgery becomes the standard for localized disease.
- 1990s: Approval of Interferon-alpha as the first adjuvant therapy.
- 2011: The FDA approves Ipilimumab, the first checkpoint inhibitor, revolutionizing metastatic melanoma survival rates.
- 2013: BRAF and MEK inhibitors are introduced, offering targeted relief for patients with specific genetic profiles.
How has patient advocacy changed the landscape?
Historically, melanoma was shrouded in stigma and fear. Today, global awareness campaigns have shifted the focus toward early detection and sun safety. Within the DiseaseMaps.org community, 30 people with melanoma have shared their experiences, providing a vital support network that helps patients navigate the emotional weight of diagnosis and treatment.
Next steps
- Consult a board-certified dermatologist for regular skin cancer screenings.
- Speak with an oncologist about genetic testing (BRAF, NRAS, KIT) to determine if you are a candidate for targeted therapies.
- Join the DiseaseMaps.org community to connect with other patients and caregivers.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.
References
- NIH National Cancer Institute: Melanoma Treatment (PDQ®)
- American Cancer Society: Key Statistics for Melanoma Skin Cancer
- Orphanet: Melanoma
- Melanoma Research Alliance: Understanding Melanoma History
